FARHAD NIKOO: Open Payments
NPI 1740485101 · LAKE FOREST, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,620 in 58 payments from 13 companies in 2025. Trend: 2023 $3,061 · 2024 $2,901 · 2025 $1,620
Food & beverage: $1,620
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $391 |
| Alkermes, Inc. | 10 | $332 |
| Otsuka America Pharmaceutical, Inc. | 9 | $304 |
| Almatica Pharma LLC | 4 | $98 |
| Janssen Pharmaceuticals, Inc | 3 | $83 |
| Supernus Pharmaceuticals, Inc. | 4 | $82 |
| ABBVIE INC. | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
Products named: CAPLYTA, REXULTI, ARISTADA, LYBALVI, ABILIFY ASIMTUFII, LOREEV XR, SPRAVATO, VRAYLAR.
Industry payments across CA — which companies pay providers there.
